PMID- 19932849 OWN - NLM STAT- MEDLINE DCOM- 20100107 LR - 20141120 IS - 1097-6817 (Electronic) IS - 0194-5998 (Linking) VI - 141 IP - 6 DP - 2009 Dec TI - Immunologic response to fungus is not universally associated with rhinosinusitis. PG - 750-6.e1-2 LID - 10.1016/j.otohns.2009.09.016 [doi] AB - OBJECTIVE: Immunologic response to fungal antigens has been cited as an etiologic factor in chronic rhinosinusitis (CRS). Previous work demonstrated a significant cytokine response in CRS patients that did not correlate with an immunoglobulin E (IgE) response. This study was performed in an effort to replicate these findings in a more geographically diverse population. DESIGN: Prospective in vitro study. SETTING: Two academic tertiary rhinologic practices in Texas and Utah. METHODS: Serum and peripheral blood monocytes (PBMC) were obtained from 10 CRS patients and seven controls. Total IgE and fungal-specific IgE levels were determined. Cytokine levels were measured after PBMC exposure to Alternaria, Aspergillus, Cladosporium, and Penicillium extracts. Correlations between cytokine responses and presence of CRS as well as IgE and IgG were determined. RESULTS: Interleukin-5 (IL-5) was produced after Alternaria extract exposure in both CRS patients and controls, but the production was heterogenous and did not correlate with the presence of CRS. IL-5 levels after Alternaria extract exposure correlated strongly with levels of Alternaria-specific IgE in both CRS patients and controls. IL-5 production did not correlate with IgG levels. IL-4, IL-13, and interferon-gamma production did not differ between CRS patients and controls. CONCLUSIONS: In contrast to previously reported data, IL-5 responses to Alternaria extract were not predictive of CRS presence. Our results in patients from Utah and Texas significantly differ from previously published findings in predominantly Midwestern patients. The immunologic response to fungal extracts appears to be heterogenous and may differ based on geography, allergy status, and/or other as-yet unknown factors. FAU - Orlandi, Richard R AU - Orlandi RR AD - Division of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA. richard.orlandi@hsc.utah.edu FAU - Marple, Bradley F AU - Marple BF FAU - Georgelas, Ann AU - Georgelas A FAU - Durtschi, Drew AU - Durtschi D FAU - Barr, Lucy AU - Barr L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Otolaryngol Head Neck Surg JT - Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery JID - 8508176 RN - 0 (Antigens, Fungal) RN - 0 (Immunoglobulin G) RN - 0 (Interleukin-5) RN - 37341-29-0 (Immunoglobulin E) SB - IM CIN - Otolaryngol Head Neck Surg. 2010 Nov;143(5):607-10. PMID: 20974326 MH - Adult MH - Aged MH - Antigens, Fungal/*immunology MH - Chronic Disease MH - Female MH - Humans MH - Immunoglobulin E/blood MH - Immunoglobulin G/blood MH - In Vitro Techniques MH - Interleukin-5/immunology MH - Male MH - Middle Aged MH - Prospective Studies MH - Rhinitis/*immunology MH - Sinusitis/*immunology MH - Texas MH - Utah EDAT- 2009/11/26 06:00 MHDA- 2010/01/08 06:00 CRDT- 2009/11/26 06:00 PHST- 2009/08/31 00:00 [received] PHST- 2009/09/21 00:00 [accepted] PHST- 2009/11/26 06:00 [entrez] PHST- 2009/11/26 06:00 [pubmed] PHST- 2010/01/08 06:00 [medline] AID - S0194-5998(09)01511-3 [pii] AID - 10.1016/j.otohns.2009.09.016 [doi] PST - ppublish SO - Otolaryngol Head Neck Surg. 2009 Dec;141(6):750-6.e1-2. doi: 10.1016/j.otohns.2009.09.016.